StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.61−0.19 (-3.96%)

Close on Nov 17, 2026Market cap $57.89MP/E –Yield –

Neuraxis profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Neuraxis's profit margin for the twelve months ending Jun 30, 2026 was -144.4%. For fiscal 2025 it was -218.5%, against -306.8% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-218.5%+88.3
FY2024Dec 31, 2024-306.8%+287.7
FY2023Dec 31, 2023-594.6%−416.5
FY2022Dec 31, 2022-178.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-108.1%+80.9
Q1 FY2026Mar 31, 2026-109.5%+144.9
Q4 FY2025Dec 31, 2025-176.5%+13.7
Q3 FY2025Sep 30, 2025-261.6%+1.7
Q2 FY2025Jun 30, 2025-189.1%+288.1
Q1 FY2025Mar 31, 2025-254.4%+73.5
Q4 FY2024Dec 31, 2024-190.2%+109.4
Q3 FY2024Sep 30, 2024-263.3%+1543.2
Q2 FY2024Jun 30, 2024-477.1%−131.1
Q1 FY2024Mar 31, 2024-328.0%−58.0
Q4 FY2023Dec 31, 2023-299.6%−297.4
Q3 FY2023Sep 30, 2023-1806.5%−1470.4
Q2 FY2023Jun 30, 2023-346.1%−123.9
Q1 FY2023Mar 31, 2023-270.0%–
Q4 FY2022Dec 31, 2022-2.2%–
Q3 FY2022Sep 30, 2022-336.1%–
Q2 FY2022Jun 30, 2022-222.2%–

More Neuraxis figures

See a number that looks wrong?